Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MBQ-167
Cat. No.:
OB0225LY-0060
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
MBQ-167 is a small molecule compound that acts as a highly selective K-Ras (G12C) inhibitor by specifically binding to and inhibiting this specific mutant form of the K-Ras protein.
Synonym:
2097938-73-1; 9-Ethyl-3-(5-phenyl-1H-1,2,3-triazol-1-yl)-9H-carbazole; 9-Ethyl-3-(5-phenyltriazol-1-yl)carbazole; 9-Ethyl-3-(5-phenyl-1,2,3-triazol-1-yl)carbazole; 1-(9-Ethyl-9H-carbazol-3-yl)-5-phenyl-H-1,2,3-triazole
CAS No.:
2097938-73-1
Compound CID:
129896932
Formula:
C22H18N4
Formula Weight:
338.41
Specification
Relative Density:
1.23 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MBQ-167 has important applications in cancer and metabolic disease research.
Library Information
Targets:
GTPase superfamily; Kinases
Receptors:
Cdc42; CDK; Ras; Ras 1/2/3
Pathways:
GPCR/G protein; Cell cycle/Checkpoint; MAPK
Plate Number:
AOCL-1
Plate Location:
g2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
155 mg/mL; 458.02 mM
Water Max Solubility:
<0.1 mg/mL (insoluble)
